RAPT Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -36.15M-43.00M-52.89M-69.20M-85.80M-127.06M
Share-based Compensation 1.17M2.05M8.69M9.95M11.26M17.09M19.93M
Gains from Sales and Divestitures 0.01M0.01M0.01M
Gains from Investment Securities 0.10M3.60M2.40M2.40M8.06M0.70M0.10M
Non-cash Items 11.12M38.42M9.43M23.21M
Cash from Operations -32.95M-35.47M-40.49M-61.03M-70.77M-97.05M-83.30M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.50M-1.27M0.30M5.74M2.81M
Depreciation & Amortization (CF) 1.24M1.33M1.12M1.00M1.05M1.22M1.20M
Change in Working Capital
Change in Accured Expenses 1.44M0.74M2.39M0.93M3.71M7.33M-8.46M
Other Working Capital Changes 4.00M0.96M-3.43M-2.10M-2.71M-2.85M
Investing Activities
Capital Expenditures 3.50M0.89M0.40M0.76M0.84M1.12M0.12M
Sales of Property, Plant and Equipment 0.04M
Change in Acquisitions & Divestments 52.30M84.39M146.21M266.75M135.04M
Cash from Investing Activities -3.50M-0.84M-87.44M-81.35M-45.49M104.13M52.70M
Financing Activities
Other financing activities 1.17M2.05M8.69M9.95M11.26M17.09M19.93M
Cash from Financing Activities 52.73M49.90M75.46M141.48M131.18M1.45M152.85M
Additional items
Change in Cash 16.28M13.59M-52.47M-0.89M14.92M8.53M122.26M
Free Cash Flow -36.45M-36.36M-40.89M-61.78M-71.62M-98.17M-83.42M
Net Cash Flow 16.28M13.59M-52.47M-0.89M14.92M8.53M122.25M